Amgen Inc. (AMGN) Q4 2021 Earnings Results

Amgen Beats on EPS, Stock Up 0.64%

Amgen's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. The stock's slight increase of 0.64% reflects investor confidence in the company's performance and future prospects, despite the lack of revenue data and guidance. The management's focus on innovation and pipeline development suggests a commitment to long-term growth.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$4.36	N/A	+5.29%

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed confidence in their current strategies and emphasized the importance of their product pipeline. They remain focused on delivering value to patients and shareholders.

Management highlighted strong performance in key therapeutic areas.

They noted ongoing investments in innovation and pipeline development.

Amgen Beats on EPS, Stock Up 0.64%

Key numbers

Management commentary

Amgen Inc.

More earnings this week

Amgen Beats on EPS, Stock Up 0.64%

Key numbers

Management commentary